Tianjin Lisheng Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 612.1 million compared to CNY 581.7 million a year ago. Revenue was CNY 614.74 million compared to CNY 587.33 million a year ago.

Net income was CNY 71.95 million compared to CNY 61.25 million a year ago. Basic earnings per share from continuing operations was CNY 0.39 compared to CNY 0.34 a year ago. Diluted earnings per share from continuing operations was CNY 0.39 compared to CNY 0.34 a year ago.